HGHYX Holdings — The Hartford Healthcare Fund
All 85 reported holdings of The Hartford Healthcare Fund (HGHYX) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly & Co | 12.11% | $88.34M |
| Merck & Co Inc | 6.30% | $45.97M |
| Johnson & Johnson | 5.81% | $42.33M |
| UnitedHealth Group Inc | 5.54% | $40.39M |
| Intuitive Surgical Inc | 3.62% | $26.42M |
| AbbVie Inc | 3.09% | $22.52M |
| Abbott Laboratories | 2.80% | $20.38M |
| Danaher Corp | 2.68% | $19.56M |
| Edwards Lifesciences Corp | 2.54% | $18.54M |
| CVS Health Corp | 2.44% | $17.77M |
| Vertex Pharmaceuticals Inc | 2.40% | $17.50M |
| Boston Scientific Corp | 2.32% | $16.89M |
| Elevance Health Inc | 2.06% | $15.00M |
| Cencora Inc | 2.05% | $14.96M |
| Thermo Fisher Scientific Inc | 1.88% | $13.67M |
| Regeneron Pharmaceuticals Inc | 1.86% | $13.56M |
| HCA Healthcare Inc | 1.80% | $13.14M |
| Biogen Inc | 1.34% | $9.75M |
| Gsk PLC | 1.30% | $9.46M |
| Cardinal Health Inc | 1.27% | $9.23M |
| Agilent Technologies Inc | 1.27% | $9.23M |
| United Therapeutics Corp | 1.18% | $8.63M |
| Medtronic PLC | 1.18% | $8.59M |
| Stryker Corp | 1.17% | $8.50M |
| Dexcom Inc | 1.01% | $7.34M |
| Argenx SE | 0.90% | $6.57M |
| Steris PLC | 0.85% | $6.18M |
| Incyte Corp | 0.81% | $5.90M |
| Ionis Pharmaceuticals Inc | 0.81% | $5.90M |
| Ucb SA | 0.79% | $5.78M |
| Alnylam Pharmaceuticals Inc | 0.77% | $5.61M |
| Bristol-Myers Squibb Co | 0.73% | $5.34M |
| Ascendis Pharma A/S | 0.72% | $5.24M |
| Madrigal Pharmaceuticals Inc | 0.72% | $5.24M |
| Elanco Animal Health Inc | 0.66% | $4.81M |
| Encompass Health Corp | 0.66% | $4.78M |
| Kailera Therapeutics Inc | 0.65% | $4.70M |
| HeartFlow Inc | 0.60% | $4.40M |
| Galderma Group AG | 0.59% | $4.28M |
| Arcus Biosciences Inc | 0.56% | $4.09M |
| Bio-Techne Corp | 0.55% | $4.04M |
| Protagonist Therapeutics Inc | 0.55% | $4.03M |
| Cytokinetics Inc | 0.55% | $3.99M |
| Icon PLC | 0.55% | $3.98M |
| Pharvaris NV | 0.53% | $3.83M |
| Viridian Therapeutics Inc | 0.51% | $3.75M |
| Avantor Inc | 0.51% | $3.74M |
| Mirum Pharmaceuticals Inc | 0.51% | $3.69M |
| Disc Medicine Inc | 0.51% | $3.69M |
| Revolution Medicines Inc | 0.47% | $3.45M |
| PTC Therapeutics Inc | 0.47% | $3.42M |
| Scholar Rock Holding Corp | 0.45% | $3.26M |
| GenFleet Therapeutics Shanghai Inc | 0.45% | $3.25M |
| Kymera Therapeutics Inc | 0.43% | $3.13M |
| Dianthus Therapeutics Inc | 0.42% | $3.08M |
| Adaptive Biotechnologies Corp | 0.42% | $3.08M |
| Acadia Healthcare Co Inc | 0.42% | $3.07M |
| Alignment Healthcare Inc | 0.42% | $3.05M |
| Immunocore Holdings PLC | 0.42% | $3.03M |
| Celldex Therapeutics Inc | 0.42% | $3.03M |
| Oculis Holding AG | 0.41% | $3.02M |
| Structure Therapeutics Inc | 0.41% | $2.98M |
| Apogee Therapeutics Inc | 0.41% | $2.96M |
| Inspire Medical Systems Inc | 0.40% | $2.92M |
| Qiagen NV | 0.40% | $2.91M |
| AstraZeneca PLC | 0.40% | $2.90M |
| Option Care Health Inc | 0.40% | $2.90M |
| Mineralys Therapeutics Inc | 0.37% | $2.71M |
| Immunome Inc | 0.37% | $2.69M |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 0.36% | $2.65M |
| Xenon Pharmaceuticals Inc | 0.36% | $2.65M |
| Stoke Therapeutics Inc | 0.35% | $2.52M |
| Trevi Therapeutics Inc | 0.34% | $2.48M |
| Vaxcyte Inc | 0.34% | $2.46M |
| Centene Corp | 0.33% | $2.41M |
| Natera Inc | 0.33% | $2.41M |
| Crinetics Pharmaceuticals Inc | 0.30% | $2.22M |
| Fixed Income Clearing Corp. | 0.30% | $2.18M |
| Bridgebio Pharma Inc | 0.23% | $1.71M |
| Newamsterdam Pharma Co NV | 0.21% | $1.54M |
| State Street Global Advisors | 0.20% | $1.44M |
| Nuvalent Inc | 0.20% | $1.43M |
| CG oncology Inc | 0.13% | $914.67K |
| Alamar Biosciences Inc | 0.03% | $227.86K |
| Contra Abiomed, Inc. | 0.00% | $7.56K |
HGHYX overview: performance, fees, allocation and SEC filings